Filing Details
- Accession Number:
- 0001209191-14-051260
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-07 19:51:08
- Reporting Period:
- 2014-08-07
- Filing Date:
- 2014-08-07
- Accepted Time:
- 2014-08-07 18:51:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
949699 | Pharmacyclics Inc | PCYC | Pharmaceutical Preparations (2834) | 943148201 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1559226 | Jesse Mcgreivy | C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-08-07 | 3,645 | $25.33 | 3,645 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-08-07 | 18,750 | $89.52 | 22,395 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-08-07 | 11,667 | $61.60 | 34,062 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-07 | 34,062 | $120.92 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-07 | 3,645 | $0.00 | 3,645 | $25.33 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-07 | 11,667 | $0.00 | 11,667 | $61.60 |
Common Stock | Common Stock | Disposition | 2014-08-07 | 18,750 | $0.00 | 18,750 | $89.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,313 | 2012-04-16 | 2022-04-16 | No | 4 | M | Direct |
23,333 | 2013-04-11 | 2026-10-26 | No | 4 | M | Direct |
56,250 | 2013-07-09 | 2023-07-09 | No | 4 | M | Direct |
Footnotes
- The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on April 16, 2013 and 1/36th of the remaining shares will vest monthly thereafter.
- The option vests 6/48 on April 11, 2013; the remainder vests proportionately on each of April 11, 2014, April 11, 2015 and April 11, 2016. The vesting of the options are subject to satisfaction of certain performance criteria.
- The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on each of July 9, 2014, July 9, 2015; July 9, 2016; July 9, 2017. The vesting of the options is subject to satisfaction of certain performance criteria.